Juliet V. Spencer, Ph.D.
Interim Dean, College of Arts & Sciences
Professor of Biology
/prod01/twu-cdn-pxl/media/images/faculty-profiles/JSpencer7twuedu.jpg)
Contact
JSpencer7@twu.edu
940-898-3326
Dean's Office
College of Arts & Sciences
CFO 1210
Denton, TX 76204
Biography
Juliet V. Spencer is a Professor of Biology at Texas Woman's University. She completed graduate and post-doctoral training at the University of Virginia and the gained additional post-doctoral training at ChemoCentryx, Inc., a biotechnology start-up in the San Francisco Bay Area. Dr. Spencer worked as a Senior Scientist in Drug Discovery at Ceretek, LLC for several years before starting her academic career at the University of San Francisco. Dr. Spencer joined the faculty at TWU in 2018 as Professor and Chair of Biology. Her lab focuses on herpesviruses and understanding how these viruses manipulate the human immune system. Other research projects investigate virus evolution and the role of virus infection in the development and progression of cancer. She has a strong commitment to mentoring students in research and has been recognized by the Association of Women in Science for her outstanding mentorship of female students. Her recent work also investigates factors associated with student succes in STEM fields and development of a science identity. In 2021, Dr. Spencer was appointed as Director of the School of the Sciences, which includes Biology, Chemistry & Biochemistry, Computer Science, and Mathematics.
Education
Ph.D., Microbiology, University of Virginia, Charlottesville, VA
M.B.A., Business Administration, Texas Woman's University, Denton, TX
B.S., Biotechnology, Worcester Polytechnic Institute, Worcester, MA
Research Interests
Herpesviruses; Virus-host Interactions; Viral Immune Modulation; Virus Evolution
Latest Articles
Classroom Leadership: Empowering Faculty with Management Strategies
Academic Leader (2025)
Shazia Ahmed, Juliet V Spencer
Book Review: A Toolbox for Department Chairs: A Compilation for The Chronicle of Higher Education.
Department Chair (2024)
Juliet V. Spencer
Cytokine levels in breast cancer are highly dependent on cytomegalovirus (CMV) status.
Breast Cancer Research & Treatment (2024)
Juliet V. Spencer, Jianfang Li, Brenda Deyarmin, Hai Hu, Craig D. Shriver
The Three Most Important Words in Faculty Workload: Transparency, Transparency, Transparency.
Department Chair (2023)
Juliet V. Spencer, Dewaynna Horn
Fueling Faculty Funding: 5 Tips for Promoting Grant Success in Your Department.
Department Chair (2022)
Juliet V. Spencer
Detection of cytomegalovirus interleukin 10 (cmvIL-10) by enzyme linked immune sorbent assay (ELISA)
Methods in Molecular Biology (2021)
Vivian P Young, Margarette C Mariano, Lionel Faure, Juliet V. Spencer
Why You Should Be A Selfish Instructor
Faculty Focus (2021)
Shazia A Ahmed, Juliet V. Spencer
Making Lemonade for Adjunct Faculty
Department Chair (2021)
Juliet V. Spencer, Amy Jo M. Hammett, Youlonda FitzGerald
Productive Infection of Human Breast Cancer Cell Lines with Human Cytomegalovirus (HCMV)
Pathogens (2021)
Kaitlin M. Branch, Erica C. Garcia, Y.M. Chen, M. McGregor, M. Min
Identification of a novel signaling complex containing host chemokine receptor CXCR4, Interleukin-10 receptor, and human cytomegalovirus US27
Virology (2020)
Carolyn C. Tu, Christine M. O'Connor, Juliet V. Spencer
Editorial: Cytokine-mediated Organ Dysfunction and Tissue Damage Induced by Viruses
Frontiers in Immunology (2020)
J V Spencer, P Religa, M H Lehmann
Herpes Simplex Virus: A Versatile Tool for Insights Into Evolution, Gene Delivery, and Tumor Immunotherapy
Virology: Research & Treatment (2020)
P H Mody, S Pathak, L K Hanson, J V Spencer
Control of Cytokines in Latent Cytomegalovirus Infection.
Pathogens (2020)
Pearley Chinta, Erica C Garcia, Kiran H Tajuddin, Naomi Akhidenor, Davis Allyson
Who Let the Dogs Out? A Plea for Official Guidelines on Service Animals in the Teaching Laboratory
Journal of Microbiology and Biology Education (2019)
Amy Jo M Hammett, Juliet V Spencer
The human cytomegalovirus US27 gene product constitutively activates antioxidant response element (ARE)-mediated transcription through Gβγ, phosphoinositide 3-kinase (PI3K), and nuclear respiratory factor 1 (NRF-1)
Journal of Virology (2018)
J M Boeck, G A Stowell, C M O'Connor, J V Spencer
Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms
Journal of Virology (2018)
C C Tu, K L Arnolds, C M O'Connor, J V Spencer
Human cytomegalovirus interleukin-10 enhances matrigel invasion of MDA-MB-231 breast cancer cells
Cancer Cell International (2017)
C A Valle Oseguera, J V Spencer
Effect of Human Cytomegalovirus (HCMV) US27 on CXCR4 Receptor Internalization Measured by Fluorogen-activating Protein (FAP) Biosensors
PLoS ONE (2017)
J M Boeck, J V Spencer
Modulation of the Host Environment by Human Cytomegalovirus with Viral Interleukin 10 in Peripheral Blood
Journal of Infectious Diseases (2017)
V P Young, M C Mariano, K M Allaire, C C Tu, S Avdic
Evolution of the ability to modulate host chemokine networks via gene duplication in human cytomegalovirus (HCMV)
Infection, Genetics and Evolution (2017)
J A Scarborough, J R Paul, J V Spencer
Human Cytomegalovirus interleukin-10 promotes proliferation and migration of MCF-7 breast cancer cells
Cancer Cell & Microenvironment (2015)
R K Bishop, C O Valle Oseguera, J V Spencer
Viral manipulation of the host immune response
Current Opinion in Immunology (2015)
A Christiaansen, S M Varga, J V Spencer
Books
Cytomegalovirus Encoded G Protein-Coupled Receptors. In Cytomegalovirus Infection
SM Group Open Access eBooks (2017)
J M Boeck, J V Spencer
Current Projects
My research centers on herpesviruses and the way they interact with their human hosts. Herpesviruses are unique in their ability to establish lifelong latent infections. The immune response is usually sufficient to prevent serious disease; however, the immune system is unable to eliminate the virus from the body. Work in my laboratory is currently focused on two areas: 1) mechanisms that herpesviruses employ to modulate host immune responses and establish lifelong latency, and 2) the contribution of herpesviruses to the development or progression of cancer. This work is funded by National Institutes of Health.
Externally Funded Projects
Governor's Summer Merit Program
Texas Workforce Commission | $70,000.00 | 2024
Role: Principal Investigator
Governor's Summer Merit Program
Texas Workforce Commission | $36,400.00 | 2023
Role: Co-Principal Investigator
Scholarships and Co-curricular Activities Leading to Excellence in the Biotechnology Workforce (TWU-SCALE) Year 1 of 6
GOV-National Science Foundation (NSF) | $1,500,000.00 | 2022
Role: Principal Investigator
Modification of Host Chemokine Responses by Human Cytomegalovirus Year 5 of 5
GOV-National Institutes of Health(NIH) | $424,783.00 | 2019
Role: Principal Investigator
Internally Funded Projects
Upgrade of CytoFlex Flow Cytometer to 13 Color Analysis
Teaching and Research Grant for Equipment (TARGET Award), TWU | $60,000.00 | 2021
Research Grant
Relationship between Vitamin D levels, Cytokines, and Cytomegalovirus in Pregnant Minority Women
Jane Nelson Institute for Women's Leadership | $49,000.00 | 2021
Research Grant
Women in STEM Leadership Program
Jane Nelson Institute for Women's Leadership | $350,000.00 | 2021
Research Grant
Development of a novel mouse model for breast cancer
Jane Nelson Institute for Women's Leadership | $39,200.00 | 2021
Research Grant
Immunomodulatory Functions of Rhesus and Human Cytomegalovirus
Chancellor's Research Fellow Award, TWU | $8,000.00 | 2020
Research Grant
Role of Viral Cytokines in Breast Cancer
Research Enhancement Program (REP Award), TWU | $9,854.00 | 2020
Research Grant
Investigation of a Novel Immune Stimulatory Function of Cytomegalovirus Interleukin 10
Research Enhancement Program (REP Award), TWU | $10,000.00 | 2019
Research Grant
Professional Affiliations
- American Association for the Advancement of Science
- American Society for Microbiology
- American Society for Virology
- Sigma Xi
Page last updated 2:58 PM, April 17, 2025